Operations & Strategy

How do I evaluate a PE offer?

Evaluate a PE offer on six dimensions: enterprise value multiple, cash at close percentage, rollover equity terms, post-close compensation structure, earnout conditions, and platform exit timing assumptions.

Reviewed by Stanislav Sukhinin, CFALast reviewed April 8, 2026

Want this answered for your own clinic?

Definition

Evaluating a PE offer means analyzing total economic value across cash, equity, and post-close compensation over the full hold period, not just the headline price.

The detail

Six dimensions matter. Enterprise value multiple: compare against current market multiples for your size and specialty; the headline number should be in market range. Cash at close: typically 60 to 80 percent; lower than 60 percent is a yellow flag. Rollover equity: structure (preferred or common), participation in next exit, anti-dilution protection, governance rights. Post-close compensation: typical reduction is 20 to 40 percent of pre-close take-home; model this carefully. Earnout: tied to retained EBITDA, what trigger thresholds apply, what is the cure period for missed years. Platform exit timing: most PE platforms target 4 to 7 year hold periods; ask the buyer where they are in the cycle. The single most important question to ask: what is the PE firm's track record of second-exit returns to physician sellers in their prior platforms? That answer predicts your outcome better than any other data point. Always run a competitive process with at least three buyers; first offers are almost never best offers.

What this means for clinic owners

From Sorso

The headline multiple is the easy part to evaluate. The hard part is modeling 7 years of compensation, equity outcomes, and lifestyle changes. If you cannot do that model yourself, hire someone who can before you sign anything.

Related questions

What is a dermatology practice worth?

Dermatology practices typically sell for 4x to 7x EBITDA for single-location and add-on acquisitions, 7x to 10x for established multi-site groups, and 12x to 15x EBITDA for multi-location platforms, with cosmetic-heavy practices commanding the highest multiples.

How do PE firms value medical practices?

Private equity firms value medical practices primarily on a multiple of trailing twelve-month adjusted EBITDA, typically 5x to 12x, with the multiple driven by scale, growth, payer mix, and provider retention.

Should I sell my practice to private equity?

Selling to private equity makes sense if you want partial liquidity, want to grow with capital and infrastructure, and are willing to operate as a partner rather than sole owner; it is wrong if you want full retirement or full operational autonomy.

What is the 8-minute rule in physical therapy billing?

The 8-minute rule is a Medicare billing rule that determines how many timed CPT units (97110, 97140, etc.) a PT can bill based on total minutes spent on direct one-on-one timed services, with a single unit billable at 8 minutes minimum.

What is a MEIP in a healthcare PE deal?

A management equity incentive plan (MEIP) is a pool of equity, typically 8 to 15 percent of the post-close cap table, reserved for executives and key providers who stay with the platform, paying out at the next liquidity event.

What is an IOI in healthcare M&A?

An indication of interest (IOI) is a non-binding preliminary bid, usually providing a price range rather than a specific number, submitted after a buyer reviews the confidential information memorandum but before full diligence or LOI.

What is a non-compete in a healthcare practice sale?

A non-compete in a healthcare practice sale restricts the selling physician from opening or joining a competing practice within a defined geography and time period, typically 15 to 50 miles and 3 to 5 years, though state law enforceability varies widely.

How much does a quality of earnings report cost for a medical practice?

A sell-side quality of earnings (QoE) report for a medical practice typically costs roughly $35,000 to $100,000+, depending on practice size, complexity, and the depth of analysis. Smaller single-location practices fall at the lower end; multi-location groups and platforms with rollup activity push toward and beyond the upper end. The fee is almost always recovered in higher purchase price or smoother diligence.

Stanislav Sukhinin, CFA — Founder of Sorso
Stanislav Sukhinin, CFA

Founder of Sorso and a CFA charterholder. Before Sorso, Stan spent 19 years in corporate finance at institutions including UniCredit and Société Générale — managing a $450M loan portfolio and making senior partner at a major mezzanine lender by 29 — then built a fractional CFO firm exclusively for outpatient healthcare clinics.

Want to see how your practice measures up?

Take the 4-minute financial assessment. It is free, and it will show you where your practice is leaking money.